ADVFN US – Market Content Editor
-
Arrive AI shares jump premarket after CEO outlines strategic roadmap
Arrive AI Inc (NASDAQ:ARAI) shares climbed 15% in premarket trading on Monday after chief executive Dan O’Toole presented the company’s strategic “Plai Book,” a framework detailing its plans for growth, execution and innovation. The autonomous delivery network company, which develops AI-enabled Arrive Points for last-mile logistics, drew investor interest following O’Toole’s overview of its operating…
-
Gold Resource shares jump on agreed takeover by Goldgroup Mining
Shares of Gold Resource Corporation (AMEX:GORO) surged 17.4% in premarket trading on Monday after the company announced a definitive agreement to be acquired by Goldgroup Mining Inc. (USOTC:GGAZF) through an all-share merger. Under the agreed terms, Gold Resource shareholders will receive 1.4476 Goldgroup common shares for each Gold Resource share held. This ratio will be…
-
Envirotech Vehicles shares jump on progress in AI data center rollout
Envirotech Vehicles Inc (NASDAQ:EVTV) shares soared 42.8% in premarket trading on Monday after the company announced a major step forward in its artificial intelligence infrastructure partnership with AZIO AI Corporation. The electric vehicle maker said it has successfully delivered, installed and powered a 40-foot AI data center container engineered for immersion-cooled computing. The unit is…
-
Specificity Hits Key Milestones, Signals Accelerated Growth in 2026
This article has been disseminated on behalf of Specificity and may include a paid advertisement. Hybrid AdTech firm Specificity (USOTC:SPTY) is entering 2026 with momentum after announcing a series of financial and operational milestones that underscore its shift toward sustainable profitability and rapid expansion. In an industry grappling with fraud and inefficiency, the company’s focus on bot-free,…
-
Relay Therapeutics shares climb after Oppenheimer lifts rating
Shares of Relay Therapeutics Inc (NASDAQ:RLAY) jumped 5.8% in premarket trading on Monday after Oppenheimer upgraded the biotechnology company to Outperform from Perform and set a new price target of $14.00. Analyst Matt Biegler pointed to potential near-term catalysts for Relay’s mutant-selective inhibitor zovegalisib, particularly ahead of the upcoming VIKTORIA-1 clinical trial results for rival…
-
Revolution Medicines shares slide after Merck reportedly walks away from takeover talks
Merck & Company Inc (NYSE:MRK) has reportedly ended discussions to acquire Revolution Medicines Inc (NASDAQ:RVMD) after the two sides failed to agree on valuation, according to the Wall Street Journal, citing people familiar with the situation. The talks had centered on a potential transaction that could have valued the oncology-focused biotech at around $30 billion.…
-
CoreWeave shares jump 10% after $2 billion NVIDIA investment deepens AI alliance
CoreWeave (NASDAQ:CRWV) shares climbed 10% on Monday after NVIDIA (NASDAQ:NVDA) disclosed a $2 billion equity investment aimed at strengthening and expanding the companies’ artificial intelligence infrastructure partnership. As part of the deal, NVIDIA acquired CoreWeave Class A common shares at $87.20 apiece. The investment sits within a broader strategic collaboration focused on accelerating the development…
-
Sarepta posts encouraging three-year data for Duchenne gene therapy
Sarepta Therapeutics Inc. (NASDAQ:SRPT) released three-year follow-up results from its EMBARK study, showing that its gene therapy ELEVIDYS slowed functional decline in ambulatory patients with Duchenne muscular dystrophy. The analysis covered 52 patients who received ELEVIDYS at an average age of nine. After three years, treated patients maintained average scores on the North Star Ambulatory…
-
MannKind shares climb after FDA clears revised Afrezza prescribing label
MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration has approved changes to the prescribing information for its Afrezza inhaled insulin. The revised label is intended to give healthcare professionals more explicit guidance on initial dosing when switching patients from subcutaneous mealtime insulin—whether via multiple daily…
-
Steel Dynamics stock advances after Q4 profit tops forecasts
Steel Dynamics, Inc. (NASDAQ:STLD) shares climbed 2.6% after the company reported fourth-quarter earnings that came in ahead of market expectations, even as revenue missed consensus estimates. The steelmaker delivered net income of $266 million for the quarter, equal to $1.82 per diluted share, beating analysts’ forecasts of $1.69 per share. Quarterly revenue totaled $4.4 billion,…